Bloodwork question about pramiracetam. Baseline, a fortnight in, and the numbers moved in a direction I did not expect.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took a fortnight to be sure.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Vivid dreams are reported widely and are not in the label because there is not really a label.
Would like a narrow answer rather than an enthusiastic one.
Same here.
What is the first thing you would read if you were starting from zero? Headaches was my main issue with pramiracetam too.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.